Selected article for: "IL software and statistical analysis"
Author: Lee, Chang-Seop; Lee, Ju-Hyung; Oh, Mira; Choi, Kyung-Min; Jeong, Mi Ran; Park, Jong-Dae; Kwon, Dae Young; Ha, Ki-Chan; Park, Eun-Ock; Lee, Nuri; Kim, Sun-Young; Choi, Eun-Kyung; Kim, Min-Gul; Chae, Soo-Wan
Title: Preventive Effect of Korean Red Ginseng for Acute Respiratory Illness: A Randomized and Double-Blind Clinical Trial
  • Document date: 2012_12_7
    • ID: v07crluc_20
    Snippet: Statistical analysis was done by a statistician under blinded conditions. The efficacy analysis was done only with subjects who completed the study (per protocol, PP group), whereas the frequency rate of ARI was done using the Fisher's exact test. Symptom duration and score were analyzed with the Mann Whitney U test and Fisher's exact test. The safety assessment was also done only with subjects that completed the study (per protocol, PP group), a.....
    Document: Statistical analysis was done by a statistician under blinded conditions. The efficacy analysis was done only with subjects who completed the study (per protocol, PP group), whereas the frequency rate of ARI was done using the Fisher's exact test. Symptom duration and score were analyzed with the Mann Whitney U test and Fisher's exact test. The safety assessment was also done only with subjects that completed the study (per protocol, PP group), and the analysis between the two groups were done using the Mann Whitney U test and Fisher's exact test. We used the repeated measure analysis of variance (ANOVA) to compare the laboratory findings between two groups before and after clinical trial. SPSS software ver 19.0 (SPSS Inc., Chicago, IL, USA) was used for all analyses and P values of less than 0.05 were considered statistically significant.

    Search related documents:
    Co phrase search for related documents
    • ANOVA variance and USA IL Chicago SPSS analysis: 1, 2
    • ARI frequency rate and score symptom duration: 1, 2
    • ARI frequency rate and symptom duration: 1, 2
    • clinical trial and score symptom duration: 1, 2
    • clinical trial and statistical analysis: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
    • clinical trial and symptom duration: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12
    • efficacy analysis and statistical analysis: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19
    • exact test and safety assessment: 1
    • exact test and score symptom duration: 1
    • exact test and statistical analysis: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
    • exact test and symptom duration: 1, 2, 3, 4, 5
    • exact test and USA IL Chicago SPSS analysis: 1, 2, 3
    • Fisher exact test and statistical analysis: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24
    • Fisher exact test Mann Whitney test and statistical analysis: 1
    • frequency rate and score symptom duration: 1, 2
    • frequency rate and symptom duration: 1, 2, 3
    • group analysis and score symptom duration: 1
    • group analysis and statistical analysis: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
    • group analysis and symptom duration: 1, 2, 3